C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/02 (2006.01) A61K 31/7115 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2542232
Aspects featured in the invention relate to compositions and methods for inhibiting alpha-synuclein (SNCA) gene expression, such as for the treatment of neurodegenerative disorders. An anti- SNCA agent featured herein that targets the SNCA gene can have been modified to alter distribution in favor of neural cells.
Les aspects présentés dans cette invention concernent des compositions et des procédés d'inhibition de l'expression génique alpha-synucléine (SNCA), notamment utilisés dans le traitement de troubles neurodégénératifs. Un agent anti-SNCA présenté dans cette invention qui cible le gène SNCA peut avoir été modifié de manière à altérer la répartition en faveur des cellules neurales.
Bumcrot David
Farrer Matthew J.
Maraganore Demetrius M.
Vornlocher Hans-Peter
Alnylam Pharmaceuticals Inc.
Mayo Foundation For Medical Education And Research
Smart & Biggar
LandOfFree
Method of treating neurodegenerative disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating neurodegenerative disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating neurodegenerative disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1753545